Umm you completely missed my point. I just don't trust the company. Too many funnels of shareholder funds to external parties such as creditors, Alto, acquisition partners, etc as well as constant excuses to do so, I don't think management can be that incompetent by accident with acquisitions and funding options and find it all very questionable.
As a startup remuneration and expenses should be conservative and aligned with the value of the company. That is not the case here.
I could be wrong, that's just my view.
- Forums
- ASX - By Stock
- CTV
- EN1 Renaissance
EN1 Renaissance, page-34
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online